|
| related topics |
| {product, liability, claim} |
| {customer, product, revenue} |
| {product, market, service} |
| {property, intellectual, protect} |
| {stock, price, operating} |
| {acquisition, growth, future} |
| {operation, natural, condition} |
| {control, financial, internal} |
|
|
If our products or processes infringe upon the intellectual property of third parties, the sale of our products may be challenged and we may have to defend costly and time-consuming infringement claims.
If third-party payors do not provide reimbursement for the use of the Powerlink System, our revenues may be negatively impacted.
Substantially all of our revenue is generated from a single product, the Powerlink System, and any declines in the sale of this product will negatively impact our business.
We have a history of losses and we may incur losses in the future.
Our future operating results are difficult to predict and may vary significantly from quarter to quarter, which may negatively impact our stock price in the future.
Our business is subject to extensive governmental regulation that could make it more expensive and time consuming for us to introduce new or improved products.
If we fail to develop and maintain our direct sales force, our business could suffer.
Our third-party distributors may not effectively distribute our products.
If we fail to properly manage our anticipated growth, our business could suffer.
We rely solely on an in-house process to supply our graft material for the Powerlink System, and any disruption in our ability to produce this material could delay or prevent us from producing the product for sale.
If we are unable to protect our intellectual property, our business may be negatively affected.
If we are unable to effectively manage our inventory held on consignment by our intended customers, we will not achieve our expected results.
We may face product liability claims that could result in costly litigation and significant liabilities.
We may need to raise additional funds in the future to fund our operations.
Our operations are currently conducted at a single location that may be at risk from earthquakes or other natural disasters.
The price of our stock may fluctuate unpredictably in response to factors unrelated to our operating performance.
Full 10-K form ▸
|
|
| related documents |
| 1025573--4/2/2007--NATROL_INC |
| 1013606--3/12/2007--ENDOLOGIX_INC_/DE/ |
| 1013606--3/16/2006--ENDOLOGIX_INC_/DE/ |
| 941604--2/27/2006--COINSTAR_INC |
| 1324759--3/31/2010--Cereplast_Inc |
| 810084--4/2/2007--BIOJECT_MEDICAL_TECHNOLOGIES_INC |
| 943894--3/28/2008--EZENIA_INC |
| 1033905--3/16/2006--LUMINEX_CORP |
| 739944--3/11/2008--MEDTOX_SCIENTIFIC_INC |
| 1050007--11/30/2006--NUTRACEUTICAL_INTERNATIONAL_CORP |
| 225263--3/14/2007--NEWPORT_CORP |
| 882873--9/21/2009--UROLOGIX_INC |
| 868368--12/26/2006--ROCHESTER_MEDICAL_CORPORATION |
| 868368--12/4/2007--ROCHESTER_MEDICAL_CORPORATION |
| 1006195--3/15/2007--MATRIXX_INITIATIVES_INC |
| 225263--3/16/2006--NEWPORT_CORP |
| 739944--3/17/2006--MEDTOX_SCIENTIFIC_INC |
| 1014507--6/1/2006--SCHICK_TECHNOLOGIES_INC |
| 1005010--2/29/2008--ARTHROCARE_CORP |
| 943894--3/31/2010--EZENIA_INC |
| 739944--3/15/2007--MEDTOX_SCIENTIFIC_INC |
| 739944--3/10/2009--MEDTOX_SCIENTIFIC_INC |
| 879682--3/28/2006--PLC_SYSTEMS_INC |
| 949874--3/14/2008--YOUNG_INNOVATIONS_INC |
| 949874--3/12/2009--YOUNG_INNOVATIONS_INC |
| 1202273--3/6/2008--GOLFSMITH_INTERNATIONAL_HOLDINGS_INC |
| 1006195--6/8/2009--MATRIXX_INITIATIVES_INC |
| 868368--12/11/2009--ROCHESTER_MEDICAL_CORPORATION |
| 943894--3/24/2009--EZENIA_INC |
| 868368--12/10/2010--ROCHESTER_MEDICAL_CORPORATION |
|